Healthcare Policy Expert to Provide Strategic Insight to Growing Oncology-Focused Utilization Management Company
Atlanta, GA, January 14, 2020 — OncoHealth, the leading digital health company focused on the physical, mental and financial complexities of cancer care, has announced the appointment of Dr. Peter Bach, director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes to the company’s Board of Directors.
Dr. Bach is a well-known healthcare policy expert on the cost and value of anticancer drugs. He is leading efforts to increase the understanding of the US drug development process and develop new models for drug pricing that include value to patients. Dr. Bach has also proposed a number of strategies for Medicare to link payment to the value of healthcare services delivered.
“We are fortunate to have one of the most preeminent doctors, researchers, and healthcare policy experts as part of the OncoHealth team,” said Rick Dean, OncoHealth’s CEO. “Dr. Bach has made significant, enduring contributions not only to his own institution but to national healthcare policy. Dr. Bach’s experience working in private and public healthcare will provide strategic insight to our company as we continue to experience significant growth from our health plan partners.”
Dr. Bach has published more than 100 peer-reviewed articles in outlets such as the New England Journal of Medicine and the Journal of the American Medical Association. He has served as a mentor to 15 postdoctoral researchers and junior faculty, given more than 100 invited seminars, and been the recipient of multiple NIH grants. Dr. Bach is a member of the American Society of Clinical Investigation, the Johns Hopkins Society of Scholars, the Council on Foreign Relations, and the National Academy of Medicine.
OncoHealth is a leading digital health company dedicated to helping health plans, employers, providers, patients, and life science researchers navigate the physical, mental, and financial complexities of cancer through technology enabled services and real-world data analytics. Supporting more than 7 million people in the US and Puerto Rico, OncoHealth offers digital solutions for treatment review, real-world evidence, and virtual care across all cancer types. For more information, visit www.oncohealth.us